Document Detail


Nutritional therapy for patients undergoing hemodialysis.
MedLine Citation:
PMID:  17369714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Protein energy malnutrition (PEM) frequently appears in hemodialysis (HD) patients, and it has been established as a risk factor for morbidity and mortality. Recent studies have shown that inflammation might be a key mediator between PEM and cardiovascular events. On the other hand, it remains unknown whether over-nutrition has an implication as a risk factor for cardiovascular diseases and mortality. Although many studies have indicated that obesity seemed not to be directly associated with mortality, metabolic abnormalities including hypertriglyceridemia, a low level of high-density lipoprotein cholesterol, glucose intolerance and visceral fat accumulation are common in HD patients with over-nutrition. Furthermore, the plasma adiponectin concentration has been reported to show an inverse correlation with the visceral fat mass, and low plasma adiponectin was associated with a high susceptibility to cardiovascular events and mortality in HD patients. These results suggest that nutritional therapy for HD patients may be necessary to consider in patients with either PEM or over-nutrition.
Authors:
Hiromichi Kumagai
Related Documents :
15356964 - Plasma leptin concentration in patients with acute renal failure.
21257724 - Evaluation of the respective influence of thyroid hormones and thyrotropin on blood coa...
17660664 - Profile of diabetic patients with end-stage renal failure requiring dialysis treatment ...
8137454 - Pharmacokinetics of doxorubicin and its active metabolite in patients with normal renal...
17327384 - Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective ec...
8498304 - Electrophysiologic testing in patients who respond acutely to intravenous amiodarone fo...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Contributions to nephrology     Volume:  155     ISSN:  0302-5144     ISO Abbreviation:  Contrib Nephrol     Publication Date:  2007  
Date Detail:
Created Date:  2007-03-19     Completed Date:  2007-05-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513582     Medline TA:  Contrib Nephrol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  59-71     Citation Subset:  IM    
Affiliation:
Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan. kumagai@u-shizuoka-ken.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adiponectin / blood
Cardiovascular Diseases / etiology
Diet Therapy / methods*
Humans
Kidney Diseases / complications,  diet therapy*,  therapy*
Metabolic Syndrome X / etiology
Obesity / complications
Protein-Energy Malnutrition / etiology,  prevention & control
Renal Dialysis* / adverse effects
Risk Factors
Chemical
Reg. No./Substance:
0/Adiponectin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diet therapy in diabetic nephropathy.
Next Document:  Diet therapy in patients receiving peritoneal dialysis.